Visit Our Blog
  • About FDNA™
    • Careers at FDNA
    • Contact
  • Products
    • Face2Gene™
    • FDNA Health™
  • Blog
  • News & Publications
  • Blog

Categories
  • All
  • ACMG
  • Case Study
  • Diagnostic odyssey
  • Events/Conferences
  • Face2Gene
  • Geneticist profile
  • Genomics
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos

Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization

April 18, 2018

By FDNA Team

ACMG,Face2Gene,Phenotyping,Talks,Technology,Videos

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link>

Dr. Christine Stanley, Head of Clinical Laboratory for WuXi NextCODE, US and CLIA medical director for Q&A Diagnostics, discusses next-generation phenotyping for improved variant interpretation through integration of Face2Gene LABS with WuXi NextCODE’s variant interpretation system.

According to Dr. Stanley, the ACMG has set standards on the classification and interpretation of genetic variants, including various levels of classifications as benign, unknown or pathogenic.

There are 28 lines of evidence used for classifying these variants.

 

 

“When you look at the phenotypic line of evidence, it wasn’t one that was utilized often […] but it really could be if we make it better and more complete,” she said. “In the ACMG publication, to use the phenotype as a line of evidence in variant scoring, you really need to have high clinical sensitivity, the patient must have a well-defined clinical presentation, the gene is not subject to a lot of variation, and the family history is consistent with the mode of inheritance of the disorder.”

“The phenotype information is really critical to performing whole exome and genome interpretation,” she continued.

Dr. Stanley goes on to explain that the phenotypic information allows Wuxi to utilize this phenotypic line of evidence in their variant classification and to help reclassify variants of unknown significance into the pathogenic category.

However, according to Dr. Stanley, phenotypic information is often lacking or not provided to support NGS interpretation.

She goes on to describe how WGS or WES produce a filtered list of variants that have clinical relevance, and that the report is static from what was known at the time. According to Dr. Stanley, “what we need are tools that allow for revisable reporting” because new information—such as new understanding of gene variations, or new patient symptoms—can become known down the road. This new information, ideally, can be used to reanalyze past genomics test results, impacting medical management, clinical research or patient support.

 

 

“We really need digital tools to get there,” she said. “We have taken the FDNA tool [Face2Gene] that captures the detailed clinical phenotype, and we’ve incorporated it into WuXi’s clinical sequence analyzer in order to do that real-time variant review.”

Dr. Stanley goes on to describe how the phenotype can be broadened to include other data, such as medical imaging, biometrics, clinical notes and more, all pulled into Face2Gene and integrated with the variant interpretation.

 

 

She shows how clinical users capture the photo, anthropometric measurements, phenotypic features and more inside Face2Gene, and the application uses artificial intelligence to help the user further annotate the phenotype, resulting in a rich phenotype for the patient. From there, the clinician can pass the phenotypic data securely to WuXi by selecting WuXi from the list of labs, resulting in the data being transferred into Wuxi’s clinical sequence analyzer.

Wuxi then reviews the gene list associated with the patient’s genetic sequence, scores the variants based on the ACMG classification criteria, and uses the clinical phenotype to match up to and highlight the variant results, or to highlight variants of unknown significance that relate to the phenotype to help determine if reclassification makes sense.

 

 

Watch the recording of the talk here.

 

More entries about ACMG

ACMG
 

ACMG Meeting 2022

The FDNA team is gearing up for ACMG 2022 and we’re excited to share with you new developments and updates Read more

ACMG
 

Precision Medicine and the Integration of Next-Generation Phenotyping

By Dr. Karen Gripp, Chief Medical Officer at FDNA Next-generation phenotyping (NGP) is characterized by the use of computer learning Read more

ACMG
 

Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more

ACMG
 

Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

ACMG
 

Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Careers at FDNA™

Signup for News


* These fields are required.

© 2011-2023 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Check our Cookie Policy.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT